Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.
about
Personalized management of cirrhosis by non-invasive tests of liver fibrosis.Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.Noninvasive Measures of Liver Fibrosis and Severity of Liver Disease.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic SteatohepatitisLow serum hyaluronic acid levels associated with spontaneous HBsAg clearance.Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C CoinfectionThe Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.The nanomechanical signature of liver cancer tissues and its molecular origin.Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients.Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B.Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
P2860
Q26777483-73E2639B-B364-44AD-BC87-F4A8E9668BFAQ30362068-9AFF8AD1-1E1A-4D50-8F30-8F73F632806DQ30381236-6CBC2454-010F-484F-B10D-F38562C9A694Q30391932-5054CC53-C21D-4446-BC94-7A346A5F6100Q35666218-28453590-2878-4BA1-83E8-90134557A772Q36167463-70209862-3AE5-414A-A217-AA6AFF984B52Q37014002-15A5B8DB-C188-4F0D-AF90-754B42F354EFQ38535634-444C656B-18B9-4DBA-89E8-498F993F1444Q38853674-03532B6A-B29A-4128-9F79-113C767F1247Q41065754-CF620E96-96B7-467F-BC41-DED9F9AC0B21Q41565564-EC5745FB-C272-4C38-8CC9-C8047DC8A9F6Q42365178-ACADF964-6408-401E-954A-0F8F7521499AQ47630903-52FDEEA9-2414-4E63-BE0F-F64824B05691Q48155717-D5C73507-29E3-473D-8CB0-5C10FB8D43D1
P2860
Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Risk assessment of clinical ou ...... enhanced liver fibrosis test.
@en
Risk assessment of clinical ou ...... enhanced liver fibrosis test.
@nl
type
label
Risk assessment of clinical ou ...... enhanced liver fibrosis test.
@en
Risk assessment of clinical ou ...... enhanced liver fibrosis test.
@nl
prefLabel
Risk assessment of clinical ou ...... enhanced liver fibrosis test.
@en
Risk assessment of clinical ou ...... enhanced liver fibrosis test.
@nl
P2093
P2860
P356
P1433
P1476
Risk assessment of clinical ou ...... g enhanced liver fibrosis test
@en
P2093
Beom Kyung Kim
Do Young Kim
Eun Jin Yoo
Hyon-Suk Kim
Jun Yong Park
Seung Up Kim
Young Nyun Park
P2860
P304
P356
10.1002/HEP.27389
P407
P577
2014-12-01T00:00:00Z